- Home
- BIAF vs PETZ Comparison
BIAF vs PETZ Comparison
Compare BIAF & PETZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BIAF | PETZ |
|---|---|---|
| Founded | 2014 | 2002 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Steel/Iron Ore |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.8M | 10.0M |
| IPO Year | 2022 | 2017 |
Fundamental Metrics
Financial Performance| Metric | BIAF | PETZ |
|---|---|---|
| Price | $1.17 | $0.94 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 79.8K | 10.4K |
| Earning Date | 11-14-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.26 |
| Revenue | ★ $6,776,739.00 | $1,046,006.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $20.04 | N/A |
| P/E Ratio | ★ N/A | $5.71 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.11 | $0.65 |
| 52 Week High | $46.53 | $1.68 |
Technical Indicators
Market Signals| Indicator | BIAF | PETZ |
|---|---|---|
| Relative Strength Index (RSI) | 33.86 | 41.21 |
| Support Level | $1.11 | $0.92 |
| Resistance Level | $1.32 | $1.03 |
| Average True Range (ATR) | 0.12 | 0.05 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 10.33 | 29.33 |
Price Performance
Historical ComparisonAbout BIAF bioAffinity Technologies Inc.
bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.
About PETZ TDH Holdings Inc.
TDH Holdings Inc is engaged in the business of manufacturing and selling pet food and restaurant operations. The company has two operating segments, which include Petfood sales and the Restaurant business. It has a focus on the Restaurant business segment and generates the majority of its revenue.